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Since, the primary site of drug metabolism is the liver, that plays a major role in metabolism, digestion, 
detoxification, and elimination of substances from the body, the present studies were designed to 
investigate the possible adverse effect of alcoholic extract of seeds of Lepidium sativum (LSA) and 
Lepidium sativum seed oil (LSO) on HepG2 cells, a human liver cell line. LSA and LSO induced cell 
viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and neutral red uptake 
(NRU) assays. Morphological changes, lipid peroxidation, glutathione, catalase, and superoxide 
dismutase activities in HepG2 cells were studied. Cells were exposed to 25 to 1000 µg/ml of LSA and 
LSO for 24 h. The results show that LSA and LSO reduced cell viability, and altered the cellular 
morphology in dose dependent manner. Concentrations (100 to 1000 µg/ml) of LSA and LSO were found 
to be cytotoxic, whereas 50 µg/ml and lower concentrations did not cause any significant adverse effect 
in cell viability of HepG2 cells. LSA and LSO were also found to induce oxidative stress in dose-
dependent manner indicated by decrease in glutathione level, catalase activity, and SOD activity and an 
increase in lipid peroxidation. The results indicate that LSA and LSO induced oxidative stress mediated 
cytotoxicity in HepG2 cells. 
  





Garden cress (Lepidium sativum) has been widely used 
to treat a number of ailments in traditional system of 
medicine. Lepidium sativum (L. sativum) is a fast-growing 
edible herb that belongs to the family Cruciferae 
(Brassicaceae; mustard family), and is being cultivated as 
culinary vegetable in North America, Europe, and all over 
Asia including India (Nadkarni, 1976). Also, this is a 
popular herbal plant grown in many regions of Saudi 
Arabia, such as Hijaz, AL-Qaseem, and the Eastern 
Province and is called “Habel Rashaad” or “Thufa” (Ageel 
et al., 1987; Rahman et al., 2004). In Europe and Ame-
rica, the leaves are used in salad. In various countries of 
Africa, Lepidium sativum seeds are thought to be an 
effective medicinal remedy to cure respiratory disorders, 
like bronchitis and asthma (Kloos, 1976; Nadkarni, 1976). 
The edible whole seed is known to have health promoting 
properties hence; it was assumed that these seeds can 
serve as raw material for functional foods; its peppery 
tangy flavor and aroma (Snehal et al., 2012; Rehman et 
al., 2012). L. sativum plant is known to contain ascorbic
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acid, β-carotenes, linoleic acid, palmitic acid, stearic acid 
(Duke et al., 1992), sinapic acid and sinapin (Schultz and 
Gmelin, 1952), and imidazole, lepidine, semilepidinoside 
A and B (Maier et al., 1998). L. sativum seeds are known 
to be useful as poultices for sprains, and in leprosy, skin 
diseases, dysentery, diarrhoea, splenomegal and asthma 
(Kirtikar and Basu, 2006). Seeds of L. sativum contain 
carbohydrate, protein, fatty acid, riboflavin, niacin, flavor-
noids, isothiocynates glycoside, essential aromatic oils, 
and fatty oils (Nadakarni, 1995). Previous studies showed 
that L. sativum have antiasthmatic (Paranjape and 
Mehta, 2006), bronchodilatory (Mali et al., 2008), anti-
inflammatory, analgesic, anticoagulant (Al-Yahya et al., 
1994), antirheumatic (Ahsan et al., 1989), hypoglycemic 
(Patole, 1998), laxative, prokinetic (Rehman et al., 2011), 
antihypertensive (Maghrani et al., 2005) and diuretic 
(Patel et al., 2009) activities. The aqueous seeds extract 
of L. sativum showed hypoglycemic activity, and were 
used in the treatment of bronchial asthma (Archana and 
Mehta, 2006).  
L. sativum have been widely used to treat a number of 
ailments in traditional system of medicine throughout 
India. Preliminary phytochemical study of L. sativum showed 
presence of flavonoids, coumarins, sulphur glycosides, 
triterpenes, sterols and various imidazole alkaloids (Patel 
et al., 2009). The major secondary compounds of this 
plant are glucosinolates (Gill and Macleod, 1980). The 
alkaloids of L. sativum are member of the rare imidazole 
alkaloids that is known as lepidine (Maier et al., 1998). 
Despite the widespread traditional/edible uses of L. 
sativum, there are very few reports in the literature 
available regarding the toxicity of L. sativum. In one of the 
study, investigators have shown that seeds of L. sativum 
in Wistar albino rats treated for 6 weeks did not cause 
any toxicity at 2%, but caused toxicity at 10% (w/w) 
(Adam, 1999). In another study, Datta et al. (2011) found 
that clinical enzymes viz., lactate dehydrogenase (LDH), 
serum glutamic pyruvate transaminase (SGPT) were 
within normal levels, however, the serum ALP and SGOT 
were significantly increased in male rats receiving 5 and 
10% of L. sativum seeds (Datta et al., 2011). Hepatoto-
xicity in rats fed with suspension of L. sativum seed 
extract at 2, 4 and 8 g/100 ml in albino rats fed with high 
doses of seeds have also been reported (Bafeel and Ali, 
2009).  
Thus, the present investigations were carried to study 
the cytotoxicity and oxidative stress induced by L. sativum 
seeds in human hepatocarcinoma cell line HepG2. 
 
 
MATERIALS AND METHODS 
 
Chemicals and consumables 
 
DMEM culture medium, antibiotics-atimycotic solution, fetal bovine 
serum (FBS) and trypsin were purchased from Invitogen, Life 
Sciences, USA. Consumables and culture wares used in the study 
were procured from Nunc, Denmark. Ethanol and all other specified 
reagents and solvents were purchased from Sigma Chemical 
Company Pvt. Ltd. St. Louis, MO, USA. 




Plant material and extractions 
 
The L. sativum seeds used in this work were obtained from the local 
market of Riyadh, Saudi Arabia. The seeds were screened ma-
nually to remove bad ones. They were then dried to constant weight 
in an oven at 70°C, ground using mechanical grinder, put in air-tight 
containers and stored in a desiccator.  
The oil from L. sativum seeds was extracted by continuous 
extraction in Soxhlet apparatus for 12 h using petroleum ether (60 
to 80°C boiling range) as a solvent according to the method des-
cribed by AOCS (Horwitz, 1980). At the end of the extraction, the 
solvent was evaporated. The oil thus obtained was dried over anhy-
drous sodium sulphate and stored at -4°C for further analysis. 
For the preparation of alcoholic extract, the seeds were mace-
rated in alcohol and then filtered. The procedure was repeated 
several times. The solvent was then evaporated using a rotary 






Human hepatocellular carcinoma cell line (HepG2) was cultured in 
DMEM, supplemented with 10% FBS, 0.2% sodium bicarbonate 
and antibiotic/antimycotic solution (100x, 1 ml/100 ml of medium). 
Cells were grown in 5% CO2 at 37°C in high humid atmosphere. 
Before the experiments, viability of cells was assessed following the 
protocol of Siddiqui et al. (2008). HepG2 cells showing more than 
95% cell viability and passage number between 12 and 14 were 





HepG2 cells were exposed to various concentrations of alcoholic 
extract (LSA) and oil (LSO) of L. sativum seeds (10 to 1000 μg/ml) 
for a period of 24 h.  Following the exposures of LSA and LSO, 
cells were subjected to assess the cytotoxic responses using MTT, 
and NRU assays. Further, cellular morphological alterations, oxide-
tive stress parameters such as glutathione, lipid peroxidation, cata-




Drug solutions  
 
The extracts of L. sativum were not completely soluble in aqueous 
medium solution; therefore the stock solutions of all the extracts 
were prepared in dimethylsulphoxide (DMSO) and diluted in culture 
medium to reach the desired concentrations. The concentration of 
DMSO in culture medium was not more that 0.1% and this medium 





Percent cell viability was assessed using the 3-(4, 5-dimethyl-
thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay as 
described (Siddiqui et al., 2008). Briefly, cells (1x10
4
) were allowed 
to adhere for 24 h CO2 incubator at 37°C in 96 well culture plates. 
After the respective exposure, MTT (5 mg/ml of stock in PBS) was 
added (10 μl/well in 100 μl of cell suspension), and plates were 
incubated for 4 h. Then, supernatants were discarded and 200 µl of 
DMSO were added to each well and mixed gently. The developed 
color was read at 550 nm using Multiwell Microplate Reader 
(Thermo Scientific, USA). Untreated sets were also run under identi- 
cal conditions and served as control. 
 
 
Neutral red uptake (NRU) assay 
 
Neutral  red  uptake  (NRU) assay was carried out following the pro- 




protocol described by Siddiqui et al. (2010). Briefly, after the res-
pective exposure, the medium was aspirated and cells were 
washed twice with PBS, and incubated for 3 h in a medium 
supplemented with neutral red (50 μg/ml). Medium was washed off 
rapidly with a solution containing 0.5% formaldehyde and 1% 
calcium chloride. Cells were subjected to further incubation of 20 
min at 37°C in a mixture of acetic acid (1%) and ethanol (50%) to 
extract the dye. The plates were read at 540 nm using Multiwell 
Microplate Reader (Thermo Scientific, USA). The values were 





Morphological changes in HepG2 cells exposed to increasing 
concentrations (10 to 1000 µg/ml) of LSA and LSO were taken 
using an inverted phase contrast microscope (OLYMPUS CKX 41) 
at 20 X magnification. 
 
 
Lipid peroxidation (LPO) 
 
Lipid peroxidation was performed using thiobarbituric acid-reactive 
substances (TBARS) protocol (Buege and Aust, 1978). Briefly, after 
the exposure, HepG2 cells were collected by centrifugation and 
sonicated in ice cold potassium chloride (1.15%) and centrifuged for 
10 min at 3000 x g. Resulting supernatant (1 ml) was added to 2 ml 
of thiobarbituric acid (TBA) reagent (15% TCA, 0.7% TBA and 
0.25N HCl) and heated at 100°C for 15 min in a boiling bath. Then 
sample was placed in cold and centrifuged at 1000 x g for 10 min. 
Absorbance of the supernatant was measured at 535 nm.  
 
 
Glutathione (GSH) content 
 
Intracellular GSH content was estimated as described by Chandra 
et al. (2002) with specific modifications. Briefly, after respective 
exposure, cells were collected by centrifugation and cellular protein 
were precipitated by incubating 1 ml sonicated cell suspension with 
1 ml TCA (10%) and placed on ice for 1 h followed by a 10 min 
centrifugation at 3000 rpm. The supernatant was added to 2 ml of 
0.4 M Tris buffer (pH 8.9) containing 0.02 M EDTA followed by an 
addition of 0.01 M 5,5’-dithionitrobenzoic acid (DTNB) to a final 
volume of 3 ml. The tubes were incubated for 10 min at 37°C in 
water bath with shaking. The absorbance of yellow colour deve-
loped was read at 412 nm using multiplate reader (Thermo 





The activity of catalase in cells was assayed following the protocol 
of Sinha (1972) using H2O2 as substrate. Reaction mixture in a final 
volume of 1 ml consisted of phosphate buffer (pH 7.0), 0.08 µmol of 
H2O2 and enzyme protein. The enzyme activity was measured follo-
wing disappearance of H2O2 at 570 nm using Spectrophotometer.  
 
 
Superoxide dismutase (SOD) activity 
 
The assay of SOD activity was carried out using protocol described 
by Kakkar et al. (1984). The final volume of 3 ml contained 0.052 M 
sodium pyrophosphate buffer (pH 8.3), 186 µM phenozine metho-
sulphate (PMS), 300 µM nitroblue tetrazolium (NBT), 780 µM NADH, 
sonicated enzyme preparation and water. The reaction was started 
by addition of NADH followed by incubation at 37°C for 90 s. After 
the incubation, the reaction was stopped by the addition of 1.0 ml of 
glacial acetic acid and the content was rigorously shaken with 4.0 





trifuged, and butanol layer was separated. The colour intensity of 
chromogen in butanol was measured at 560 nm against butanol 
using a spectrophotometer. A mixture devoid of enzyme containing 





Protein estimation of each sample was done following the method 






The results are expressed as mean and standard error of means 
(SEM). One way ANOVA was employed to detect differences bet-
ween the groups of treated and control. The values showing p<0.05 





MTT and NRU assays 
 
The percent cell viability in HepG2 cells observed by MTT 
and NRU assays are presented in Figures 1 and 2. 
Cytotoxicity of alcoholic extract (LSA) and oil (LSO) of 
Lepidium sativum seeds were assessed using MTT and 
NRU assays, after exposing the HepG2 cells to 10 to 
1000 µg/ml. Figures 1A and 1B shows that LSA induced 
statistically significant (p<0.01) decrease in cell viability of 
HepG2 cells in a concentration dependent manner. HepG2 
cells exposed to 100 µg/ml concentration and above con-
centrations of LSA for 24 h were found to be cytotoxic, 
and cell viability was found to be 88% by MTT and 81% 
by NRU assays at 100 µg/ml, respectively, whereas, 
maximum reduction in cell viability at 1000 µg/ml was 
found to be 68% by MTT (Figure 1A) and 43% by NRU 
(Figure 1B) assays. Similar kind of reduction in cell via-
bility of HepG2 cells was also observed in the case of 
LSO. Figures 2A and 2B shows that LSO induced statis-
tically significant (p<0.01) decrease in cell viability of 
HepG2 cells in a concentration dependent manner. 
HepG2 cells exposed to 100 µg/ml and above concentra-
tions of LSO for 24 h were found to be cytotoxic. Cell 
viability at 100 µg/ml, was found to be 86% by MTT 
(Figure 2A) and  89% by NRU (Figure 2B) assays, 
whereas, maximum reduction in cell viability at 1000 
µg/ml was found to be 49% by MTT (Figure 2A) and 46% 
by NRU assays (Figure 2B), respectively. Concentrations 
of LSA and LSO at 50 µg/ml and lower did not cause any 
adverse effect on the viability of HepG2 cells by both the 
parameters that is, MTT and NRU assays (Figures 1 and 
2). Although both LSA and LSO were found to reduce 
significantly the cell viability in a concentration manner, 





The morphological changes observed in HepG2 cells are







Figure 1. Cytotoxicity assessments by (A) MTT and (B) NRU assays in HepG2 cells following the 
exposure of various concentrations of alcoholic extract of Lepidium sativum seeds (LSA) for 24 h. Values 




shown in Figures 3 and 4. Changes in morphology were 
found in concentration dependent manner. Cells exposed 
to 250 µg/ml and above concentrations of LSA for 24 h 
reduced the normal morphology of HepG2 cells, and cell 
adhesion capacity compared to the control (Figure 3). But 
in case of LSO, the morphology of HepG2 cells at 100 
µg/ml reduced the normal morphology and cell adhesion 
capacity compared to the control (Figure 4). Most of the 
cells exposed to 500 and 1000 µg/ml of LSA and LSO 
lost their typical morphology and appeared smaller in 
size, but the lower concentrations did not cause any 




Glutathione level in the cultured HepG2 cells exposed to 
10 to 1000 µg/ml concentration of LSA and LSO for 24 h 
is summarized in Figure 5.  The result indicates that LSA 
and LSO decreased the GSH levels in a dose dependent 
manner. Figure 5 shows a significant decrease in the 
GSH activity at higher concentrations as compared to the 
control. A concentration dependent significant decrease 
of 18, 30 and 49% (p<0.01) in GSH activity at 250, 500 
and 1000 µg/ml of LSA, whereas, 25, 38, and 54% were 
observed at 250, 500, and 1000 µg/ml of LSO, 
respectively compared to the untreated control in HepG2 







Figure 2. Cytotoxicity assessments by (A) MTT and (B) NRU assays in HepG2 cells following the exposure 
of various concentrations of Lepidium Sativum  seed oil (LSO) for 24 h. Values are mean±SE of three 









The LSA and LSO induced lipid peroxidation in HepG2 
cells are summarized in Figure 6. A concentration depen-
dent increase in lipid peroxidation was also observed. An 
increase of 18, 35, 53, 81, 95% at  50, 100, 250, 500, 
1000 µg/ml of LSA and 20, 45, 67, 92, 112% at  50, 100, 
250, 500, 1000 µg/ml of LSO, respectively were found in 





Results of the catalase activity are summarized in Figure 
7. A clear-cut significant decrease of 20% and 25% was 
observed at 250 µg/ml of LSA and LSO, respectively 
compared to the control (Figure 7). However, the effect 
on catalase level was decreased with the increase in 
concentrations that is 500 µg/ml (35 and 40%) and 1000 




Superoxide dismutase activity 
 
Figure 8 shows the pattern of SOD levels in HepG2 cells 
exposed with (10 to1000 µg/ml) to LSA and LSO for 24 h. 
A concentration dependent decrease in the level of SOD 
was observed. The decrease in SOD started at 100 µg/ml 
LSA and LSO; the results show a decrease in SOD 
activity at 100 µg/ml (15, 20% of control), 250 µg/ml (27,






Figure 3. Morphological changes in HepG2 cells exposed to various concentrations of alcoholic extract of 
Lepidium sativum seeds (LSA) for 24 h. Images were taken using an inverted phase contrast microscope 







Figure 4. Morphological changes in HepG2 cells exposed to various concentrations of Lepidium sativum seed 





35% of control), 500 µg/ml (39, 45% of control), 1000 
µg/ml (45, 50% of control) of LSA and LSO, respectively 





Leaves, roots and seeds of the plant are attributed with a 
variety of medicinal properties and are used in traditional 
medicine in various parts of India (Nadkarni, 1976), and 
the other parts of the world including Saudi Arabia (Ageel 
et al., 1987; Rahman et al., 2004). L. sativum have widely 
been used to treat a variety of diseases in traditional 
system of medicine. Phytochemical studies of L. sativum 
showed the presence of flavonoids, coumarins, sulphur 
glycosides, triterpenes, sterols and various imidazole 
alkaloids (Patel et al., 2009), and glucosinolates (Gill and 
Macleod, 1980). The seeds are traditionally used in the 
diet of lactating woman to induce milk secretion 
(Sahsrabudde and De, 1943) and in the treatment of 
some inflammatory conditions like asthma, skin disease 
and diabetes (Gill and Macleod, 1980; Maier et al., 1998). 
Despite the widespread traditional/edible uses of L. 
sativum, there is no report available in the literature on 
the toxicity of alcoholic extracts and seed oil of L.






Figure 5. Glutathione depletion in HepG-2 cells following the exposure of various concentrations of 
Lepidium sativum seed oil (LSO) and alcoholic extract of Lepidium sativum seeds (LSA) for 24 h. All 




   
Figure 6. Lipid peroxidation in HepG-2 cells following the exposure of various concentrations of 
Lepidium sativum seed oil (LSO) and alcoholic extract of Lepidium sativum seeds (LSA) for 24 h. All 
values represent the mean ±SE (*p<0.01, **p<0.001 Vs Control). 







Figure 7. Catalase activity in HepG-2 cells following the exposure of various concentrations of 
Lepidium sativum seed oil (LSO) and alcoholic extract of Lepidium sativum seeds (LSA) for 24 






Figure 8. Superoxide dismutase (SOD) activity in HepG-2 cells following the exposure of various 
concentrations of Lepidium sativum seed oil (LSO) and alcoholic extract of Lepidium sativum 
seeds (LSA) for 24 h. All values represent the mean ±SE (*p<0.01, **p<0.001 Vs Control). 




sativum. Therefore, the present investigations were initia-
ted to screen the cytotoxicity and oxidative stress induced 
by L. sativum in human hepatocarcinoma cell line 
HepG2. Our results show that alcoholic extract and oil of 
L. sativum seeds induced cytotoxicity and oxidative 
stress in HepG2 cells. In this study, we found that alco-
holic extract and oil of L. sativum seeds significantly 
reduced cell viability in HepG2 cells in a concentration 
dependent manner. The concentration at 100 µg/ml and 
above of L. sativum were found to be cytotoxic, whereas 
the concentration at 50 µg/ml and below did not show any 
significant cell death in HepG2 cells. The in vitro 
concentrations used in this study were selected from the 
previous studies showing the toxicity in this range. The 
ethanolic and seed extracts of Moringa stenopetala plant 
extracts have been shown to significantly decrease the 
cell viability of HepG2 exposed to 500 µg/ml concen-
trations (Mekonnen et al., 2005). The exposures of 
various natural products have also been investigated in 
this concentration range by various investigators in 
different in vitro models (Maria et al., 1997; Nguta et al., 
2012; Solanki et al., 2013). There are very few reports in 
the literature regarding the toxicity of L. sativum. In one of 
the study, investigators have shown that seeds of L. 
sativum in Wistar albino rats treated for 6 weeks did not 
cause any toxicity at 2%, but toxicity at 10% (w/w) 
(Adam, 1999). In another study, Datta et al. (2011) found 
that clinical enzymes viz., LDH, SGPT were within normal 
levels, however, the serum ALP and SGOT were signi-
ficantly increased in male rats receiving 5 and 10% of L. 
sativum seeds (Datta et al., 2011). Liver toxicity in rats 
fed with suspension of L. sativum seed extract at 2, 4 and 
8 g/100/ml in albino rats fed with high doses of seeds 
have also been reported (Bafeel and Ali, 2009). Our 
results also well agree with these findings, where higher 
concentrations of L. sativum induced toxicity in HepG2 
cells. Reactive oxygen species (ROS) are one of the 
important factors not only in the apoptosis process but 
also oxidative stress induced damages, DNA damage, 
and many other cellular processes. In this study, we 
found an alteration in the oxidative stress markers that 
has remarkable increase in the level of LPO and decree-
ses in antioxidant enzymes, superoxide dismutase (SOD), 
glutathione (GSH) content, and catalase activities in HepG2 
cells following the exposure of alcoholic extract and oil of 
L. sativum seeds which gradually decrease due to the 
continuously increasing concentrations. We believe that, 
the exposure of alcoholic extract and oil of L. sativum 
seeds give rise to the formation of 8-hydroxy guanosine 
and revealed the DNA damage occurring during the time 
of cells exposure to toxicant (Dusinska and Collins, 1996; 
Singh et al., 1988), and limited the burden of oxidative 
stress (Collins et al., 1993). Therefore, in our experi-
ments, when cells were exposed to alcoholic extract and 
oil of L. sativum seeds, the level of antioxidant enzymes, 
superoxide dismutase (SOD), glutathione (GSH) content, 





oxidative damage. This might be due to the ROS genera-
tion, which leads to oxidative stress to a certain extent. 
The varied biological responses of alcoholic extracts and 
oil of L. sativum seeds in the studies could be due to the 
difference in the extract, and high concentrations of L. 





This study for the first time demonstrate the concentration 
dependent cytoxicity of alcoholic extract and oil of L. 
sativum seeds in human liver cells (HepG2). A significant 
reduction in antioxidant enzymes, and increase in lipid 
peroxidation suggested their role in inducing oxidative 
stress in HepG2 cells exposed to L. sativum. This signi-
ficant variation in biological end-points in our experiments 
also revealed the utility of HepG2 cells as in vitro model 
system for the screening of various extracts of plant 
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